Literature DB >> 26097182

Robotic sleeve gastrectomy for morbid obesity: report of a 5 year experience.

Andreas Alexandrou1, Eleftherios Mantonakis1, Emmanouil Pikoulis1, Theodora Margariti1, Nikos Dimitrokallis1, Theodoros Diamantis1.   

Abstract

BACKGROUND: Robotic bariatric procedures are nowadays in the surgeon's arsenal for the treatment of morbid obesity. With proven efficacy and advantages in gastric bypass procedures, we attempted to employ robotics and study the results in the other major bariatric procedure, sleeve gastrectomy.
METHODS: We used the da Vinci S® system to perform 19 robotic sleeve gastrectomies (RSGs) and reviewed the 5-year results as far as excess body weight loss is concerned, and amelioration of obesity-related comorbidities.
RESULTS: Mean percentage of excess body weight loss (%EWL) was 64.4%, 67.1%, 61.7%, 63.1%, 64.8% for the first, second, third, fourth and fifth year, respectively. Neither of our two patients with diabetes mellitus (0%) or hypertension (0%) showed remission, while all six of our patients (100%) showed remission of their sleep apnoea after 5 years.
CONCLUSIONS: Robotic sleeve gastrectomy is an effective procedure as far as initial excess weight loss is concerned and this loss is well maintained 5 years post-operatively, a finding similar to relevant data after conventional laparoscopic sleeve gastrectomy.
Copyright © 2015 John Wiley & Sons, Ltd. Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  5-year long-term; bariatrics; morbid obesity; robotic; sleeve gastrectomy

Mesh:

Year:  2015        PMID: 26097182     DOI: 10.1002/rcs.1662

Source DB:  PubMed          Journal:  Int J Med Robot        ISSN: 1478-5951            Impact factor:   2.547


  2 in total

1.  Laparoscopic Sleeve Gastrectomy: Co-morbidity Profiles and Intermediate-Term Outcomes.

Authors:  Jonathan S Abelson; Cheguevera Afaneh; Patrick Dolan; Genevevie Chartrand; Gregory Dakin; Alfons Pomp
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

2.  Sleeve gastrectomy and hypertension: a systematic review of long-term outcomes.

Authors:  Carolyn Graham; Noah Switzer; Artan Reso; Christopher Armstrong; Neal Church; Philip Mitchell; Estifanos Debru; Richdeep Gill
Journal:  Surg Endosc       Date:  2018-11-01       Impact factor: 4.584

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.